| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1bc25afb042481b4b11750a40e927bd0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-2306
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-105 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-0271
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0606 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0735 |
| filingDate |
2007-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_482394cbaa4c56761bbac66aca05c8ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44fa9c65fbd9b376f83e7d524cde6ecd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31301f131ea64add3bf7c804fcf59b95 |
| publicationDate |
2013-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2473688-C2 |
| titleOfInvention |
Method for producing transgenic birds using embryo stem cells |
| abstract |
FIELD: medicine. n SUBSTANCE: method of avian ES cell culture provides for: a) suspension of the ES cells originated from a blastoderm disk of an embryonated non-incubated bird's egg in a culture medium containing a primary culture medium added with growth factors and animal serum; b) inoculation with the ES cell suspension produced at the stage a) of a layer of nutrient cells and further ES cell culture. The only growth factors added to said culture medium are insulin-like growth factor 1 (IGF-1) and ciliary neurotrophic growth factor (CNTF). n EFFECT: invention allows optimising the medium formulation for avian ES cell culture which enables maintaining the typical signs of the ES cells and prevent them from differentiation. n 17 cl, 9 dwg, 4 tbl, 4 ex |
| priorityDate |
2006-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |